Proteostasis Therapeutics announced plans to open two Phase 3 clinical trials of its triple combination therapy candidate for cystic fibrosis this year, after a meeting with the chief healthcare regulatory office for the U.K. One of these pivotal trials will be investigating the possibility of organoids being used for personalized medicine in CF. At the meeting, officials […]
The post Two Pivotal Phase 3 Trials of Proteostasis’ CF Triple Combo Therapy to Open in 2020 appeared first on Cystic Fibrosis News Today. |
No hay comentarios:
Publicar un comentario